Hikma Ventures Participates in CAD4.0 million Series A Financing Round for SeamlessMD to Expand Digital Patient Engagement Leadership
LONDON, Aug. 26, 2020 /PRNewswire/ --Hikma Pharmaceuticals PLC (Hikma) announces that its venture capital arm, Hikma Ventures has participated in a CAD4.0 million Series A round of financing for SeamlessMD .
- LONDON, Aug. 26, 2020 /PRNewswire/ --Hikma Pharmaceuticals PLC (Hikma) announces that its venture capital arm, Hikma Ventures has participated in a CAD4.0 million Series A round of financing for SeamlessMD .
- The round was led by MEDTEQ, bringing the company's total funding to CAD7.4 million.
- Anges Qubec, AIoT Health, and health IT entrepreneur Sanjay Malaviya also participated in the oversubscribed round.
- SeamlessMD's financing follows a period of establishing category leadership, having become the first digital patient engagement platform to hold validated, turn-key integrations with leading electronic health record companies Epic and Cerner.